Metabolic Disease
News on research and diagnostics for metabolic disorders and metabolic diseases.
The French biotech company has indicated that it will likely create a wholly owned subsidiary that will house its diagnostics work.
Renalytix AI Lands US Government Contract for Kidney Disease Test
The firm said that the contract covers early-stage kidney disease testing that can be provided by more than 140 US government departments, agencies, and affiliates.
Bio-Techne expects the acquisition will provide it with a basis to build out its IVD presence, given Asuragen's diagnostic tests and regulatory expertise.
RenalytixAI Reports Q2 2021 Revenues of $400K
For the three months ended Dec. 31, 2020, the firm reported $400,000 in pharmaceutical service revenue compared to none in 2019.
RenalytixAI Inks Deal to Introduce Kidney Function Testing Platform at University of Utah Health
RenalytixAI will provide financial support to the University of Utah in the form of sponsored research into kidney disease progression, treatment, and biomarkers.